Nov 25, 2025
- Corporate
Personnel Changes
TOKYO, November 25, 2025 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective January 1, 2026.
[Details of Personnel Changes]
Directors
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Hitoshi Iikura |
Director, Executive Vice President Supervisory responsibility for Research, Translational Research, Clinical Development, Corporate Planning and ASPIRE Transformation |
Director, Executive Vice President Supervisory responsibility for Research, Translational Research, Clinical Development and Special Mission for CVF |
Executive Officers
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Tsukasa Kusano |
Executive Vice President |
Executive Vice President |
| Kaori Ouchi |
Executive Vice President |
Executive Vice President |
| Norihisa Onozawa |
Executive Vice President |
Executive Vice President |
| Shoko Kimijima |
Executive Vice President |
Executive Vice President |
Please see the PDF file about other personnel changes.
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Hideki Sato
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp